Paid Clinical Trials Gulfport

Discover 44 paid clinical trials in Gulfport, Mississippi. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter

Filter results

Results: 44

Investigational CMV Vaccine Study for Volunteers Ages 9–15Investigational CMV Vaccine Study for Volunteers Ages 9–15

PHASE1

PHASE2

Sponsor:

Moderna

Location:

Gulfport MS, Covington LA, New Orleans LA, Birmingham ALshow 43 more

Code:

NCT05575492

Conditions

Cytomegalovirus

Eligibility Criteria

Sex: All

Age: 9 - 15

Healthy Volunteers: Accepted

Interventions

mRNA-1647

Placebo

A Study of GEn-1124 in Subjects with Acute Respiratory Distress Syndrome (ARDS)A Study of GEn-1124 in Subjects with Acute Respiratory Distress Syndrome (ARDS)

Recruiting

PHASE2

Sponsor:

GEn1E Lifesciences

Location:

Ocean Springs MS, Houston TX, Saint Louis MO, Kansas City KSshow 4 more

Code:

NCT05795465

Conditions

Respiratory Distress Syndrome, Acute

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

GEn-1124

Placebo

A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary DiseaseA Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease

Recruiting

PHASE3

Sponsor:

AstraZeneca

Location:

Gulfport MS, Mobile AL, Fairhope AL, Zachary LAshow 196 more

Code:

NCT06283966

Conditions

COPD (Chronic Obstructive Pulmonary Disease)

Eligibility Criteria

Sex: All

Age: 40 - 70+

Healthy Volunteers: Not accepted

Interventions

BGF MDI 320/14.4/9.6 μg

GFF MDI 14.4/9.6 μg

A Study to Test Whether BI 1839100 Improves Cough in People With Idiopathic Pulmonary Fibrosis or Progressive Pulmonary FibrosisA Study to Test Whether BI 1839100 Improves Cough in People With Idiopathic Pulmonary Fibrosis or Progressive Pulmonary Fibrosis

Recruiting

PHASE2

Sponsor:

Boehringer Ingelheim

Location:

Gulfport MS, Charleston SC, Oklahoma City OK, McAllen TXshow 12 more

Code:

NCT06360094

Conditions

Idiopathic Pulmonary Fibrosis

Progressive Pulmonary Fibrosis

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

BI 1839100

Placebo

To Assess the Effectiveness and Safety of Zepzelca in Adult Patients With Extensive Stage Small Cell Lung Cancer (SCLC)To Assess the Effectiveness and Safety of Zepzelca in Adult Patients With Extensive Stage Small Cell Lung Cancer (SCLC)

Recruiting

Sponsor:

Jazz Pharmaceuticals

Location:

Pascagoula MS, Marrero LA, Pensacola FL, Huntsville ALshow 47 more

Code:

NCT04894591

Conditions

Extensive-stage Small-cell Lung Cancer

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Zepzelca

A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With Heart Failure and InflammationA Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With Heart Failure and Inflammation

Recruiting

PHASE3

Sponsor:

Novo Nordisk A/S

Location:

Bogalusa LA, New Orleans LA, Fairhope AL, Hammond LAshow 160 more

Code:

NCT05636176

Conditions

Heart Failure

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Ziltivekimab

Placebo

Open-label Extension Study of Enlicitide Decanoate (MK-0616/Enlicitide Oral PCSK9 Inhibitor) in Adults With Hypercholesterolemia (MK-0616-019) CORALreef ExtensionOpen-label Extension Study of Enlicitide Decanoate (MK-0616/Enlicitide Oral PCSK9 Inhibitor) in Adults With Hypercholesterolemia (MK-0616-019) CORALreef Extension

Recruiting

PHASE3

Sponsor:

Merck Sharp & Dohme LLC

Location:

Gulfport MS, Covington LA, Daphne AL, Foley ALshow 53 more

Code:

NCT06492291

Conditions

Hypercholesterolemia

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Enlicitide Decanoate

MILD® Percutaneous Image-Guided Lumbar Decompression: a Medicare Claims StudyMILD® Percutaneous Image-Guided Lumbar Decompression: a Medicare Claims Study

Recruiting

Sponsor:

Vertos Medical, Inc.

Location:

Pascagoula MS, Slidell LA, Covington LA, Hattiesburg MSshow 1071 more

Code:

NCT03072927

Conditions

Lumbar Spinal Stenosis

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

MILD

Interspinous Process Decompression

Crizotinib in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Removed by Surgery and ALK Fusion Mutations (An ALCHEMIST Treatment Trial)Crizotinib in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Removed by Surgery and ALK Fusion Mutations (An ALCHEMIST Treatment Trial)

Recruiting

PHASE3

Sponsor:

ECOG-ACRIN Cancer Research Group

Location:

Gulfport MS, Pascagoula MS, Slidell LA, Covington LAshow 977 more

Code:

NCT02201992

Conditions

ALK Gene Rearrangement

ALK Gene Translocation

ALK Positive

Stage IB Non-Small Cell Lung Carcinoma AJCC v7

Stage II Non-Small Cell Lung Cancer AJCC v7

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Clinical Observation

Crizotinib

Laboratory Biomarker Analysis

Xenon for Neuroprotection During Post-Cardiac Arrest Syndrome in Comatose Survivors of an Out of Hospital Cardiac ArrestXenon for Neuroprotection During Post-Cardiac Arrest Syndrome in Comatose Survivors of an Out of Hospital Cardiac Arrest

Recruiting

PHASE3

Sponsor:

NeuroproteXeon, Inc.

Location:

Gulfport MS, Memphis TN, Houston TX, Gainesville FLshow 4 more

Code:

NCT03176186

Conditions

Post-Cardiac Arrest Syndrome

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Xenon

A Study of Orforglipron (LY3502970) in Adolescent Participants With Obesity, or Overweight With Related ComorbiditiesA Study of Orforglipron (LY3502970) in Adolescent Participants With Obesity, or Overweight With Related Comorbidities

Recruiting

PHASE3

Sponsor:

Eli Lilly and Company

Location:

Gulfport MS, Lafayette LA, Atlanta GA, Houston TXshow 11 more

Code:

NCT06672939

Conditions

Obesity

Overweight

Eligibility Criteria

Sex: All

Age: 12 - 17

Healthy Volunteers: Not accepted

Interventions

Orforglipron

Placebo